Keytruda plus Lenvima Approved for Certain Patients with Uterine Cancer

The United States Food and Drug Administration FDA granted accelerated approval to the combination of Keytruda pembrolizumab and Lenvima lenvatinib for the treatment of patients with advanced endometrial carcinoma that is not microsatellite instability hi [...]